Groupama consolidates insurers

THE FRENCH insurer Groupama has been operating in Slovakia under the name Groupama Garancia Poisťovòa since the start of 2012. That firm is operated under Groupama’s Hungarian subsidiary, Groupama Garancia Biztosító.

THE FRENCH insurer Groupama has been operating in Slovakia under the name Groupama Garancia Poisťovòa since the start of 2012. That firm is operated under Groupama’s Hungarian subsidiary, Groupama Garancia Biztosító.

“We have decided to entrust the management of our insurance activities in Slovakia to our Hungarian subsidiary, which is the thirdranking company in the Hungarian insurance market,” Groupama stated in early January, as quoted by the SITA newswire. “The objective of the new organisational and management model is to create a more cost-effective operation.”

The first step in the restructuring process was establishing Groupama Garancia Poisťovňa in Slovakia in October 2011, which then acquired Groupama Životná Poisťovňa and Groupama Poisťovňa, subsidiaries of Groupama of France that had offered life insurance and other forms of insurance in Slovakia.

The Hungarian subsidiary is now the owner of all Slovak insurance contracts since the purchase agreement became effective on January 1, 2012.

Groupama, based in France, provides insurance, investment and financial services to 16 million clients in 14 countries around the world. Groupama Garancia Biztosító in Hungary was formed from the merger of Hungarian insurance companies Groupama Biztosító and OTP Garancia Biztosító in 2009.

Get daily Slovak news directly to your inbox

Top stories

From COVID-19 miracle to apparent resignation to death and dying

The natural reflex of all failed politicians – and their uncritical fan clubs – is to point to cultural or geographical differences between “us” and “them”.

The COVID-19 ward in the University Hospital Martin

Developed at home, the production of Slovakia's COVID-19 vaccine will move abroad

Neuroimmunologist Norbert Žilka oversees the development of the ACvac1 vaccine at Axon Neuroscience.

Norbert Žilka is the director of the Institute of Neuroimmunology of the Slovak Academy of Sciences (SAV) and also the scientific director of Axon Neuroscience.